We are excited to introduce AURA: The world’s first end-to-end automation of the IVF lab. This is not theoretical. We are already achieving pregnancies. AURA performs the more than 200 steps necessary to combine sperm and eggs to create viable embryos. Conceivable’s AURA workcell will be operational in early 2025 and we can’t wait to work with clinicians everywhere to improve IVF outcomes, increase scale, and lower costs. Alan Murray, Joshua Abram, Alejandro Chavez-Badiola, MD, PhD, Jacques Cohen, Mina Alikani, Brian A. Levine, MD, MS, FACOG, Brian Bixon, David Sable, Aike Ho, Dr Stephanie Kuku, MD #IVFAutomation #IVF Watch the film and see the future now:
Conceivable Life Sciences
Biotechnology Research
New York, New York 3,301 followers
Pioneering the world's first end-to-end automated IVF lab.
About us
Conceivable has developed the world’s first fully automated IVF lab. Our end-to-end reinvention of today’s largely manual, artisanal labs delivers new levels of precision, quality, and scalability. Simultaneously, Conceivable brings the innovation of modern cell therapies to IVF. We are already exceeding the clinical benchmarks of today’s best IVF labs. Worldwide 95% of the infertile population–and 80% in the United States–don’t have access to IVF. Conceivable exists to change this. By automating the IVF lab we will vastly broaden the availability to this Nobel Prize winning therapy, improve results, and meet the demands of millions of infertile people wishing to achieve the dream of becoming parents.
- Website
-
https://www.conceivable.life
External link for Conceivable Life Sciences
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- New York, New York
- Type
- Privately Held
- Founded
- 2022
Locations
-
Primary
160 Mercer Street
New York, New York 10012, US
Employees at Conceivable Life Sciences
Updates
-
We think AURA has a hypnotic beauty. It is made up of connected workstations that automate the more than 200 steps to create an embryo, including: dish preparation (C:DISH), sperm preparation (C:SPERM), egg discovery and preparation (C:EGG), intracytoplasmic sperm injection, including sperm selection, immobilization, loading and injection (C:ICSI), incubation (C:CULTURE), vitrification and thawing (C:VIT) & embryo cryostorage and cryomanagement. We know that creating the world’s first end-to-end automated IVF lab would not be possible without the tireless work of the @conceivable engineering and scientist teams. It is also critical to give a shoutout for the partnership, guidance, belief, and yes, friendship of our investors. “Great things in business are never done by one person; they’re done by a team of people.” – Steve Jobs Aike Ho, D.A. Wallach, Tara Bishop MD, MPH, Fred Destin, Sofia Hmich, ACME Capital, Time BioVentures, Black Opal Ventures, Stride.VC, Future Positive #IVF #IVFAutomation #AURA #biotechnology #biotech #ivf
-
Joshua Abram is our co-founder and chairman, but perhaps as importantly, he’s our chief storyteller. A former political speechwriter and serial entrepreneur, Joshua has been business partners with our CEO, Alan Murray, for over twenty years. Together they have co-founded companies with a market value exceeding $5 billion. For Joshua, storytelling is a superpower. #IVF #IVFAutomation #storytelling
-
We love having visitors and it was so great to host our friend and investor Tara Bishop MD, MPH at our R&D center in Guadalajara. Our co-founders Alan Murray and Alejandro Chavez-Badiola, MD, PhD put her to work and the team gave a demo of our automated C:DISH workstation. Smiles all around! #IVF #IVFAutomation #biotechnology Black Opal Ventures
2 years ago, Black Opal Ventures Ventures invested in Conceivable Life Sciences back when we were barely past the napkin stage of mapping out the AI, advanced optics, and robotic components needed to automate 90% of the manual steps performed in embryogenesis. 2 days ago, Black Opal’s founder Tara Bishop MD, MPH visited our R&D lab in Guadalajara. Tara dusted off her old lab skills by preparing IVF dishes following traditional manual protocols. 2 hours later, Tara watched Conceivable’s automated C:DISH workstation label, pipette growth media, verify volumes, and cover growth media with oil. All with no human intervention. 2 minutes later a robotic handler gently guided the dishes to an incubator. The demonstration showcased how an automated IVF lab is more precise, reduces risks, and will provide better outcomes for patients. We can’t wait to have Aike Ho Fred Destin & D.A. Wallach down to see our progress. Thank you Tara for taking 2 days out of your intense schedule. #IVF #IVFAutomation #biotechnology Alejandro Chavez-Badiola, MD, PhD ACME Capital Stride Ventures Time BioVentures
-
-
Congrats to Conceivable Life Sciences UK, Alejandro Chavez-Badiola, MD, PhD, Dr Stephanie Kuku, MD, and Giuseppe Silvestri for the £2 million SMART grant win from UK Research and Innovation (Innovate UK) for our automated vitrification project! Nice work.
Exciting news for Conceivable Life Sciences and a big congratulations to CLS UK! We are incredibly honoured to share that we have been awarded the prestigious SMART grant from UK Research and Innovation (Innovate UK) for our automating vitrification project (2024-2026). It is a privilege to lead this initiative on behalf of Conceivable, and I'm excited about the impactful results our collective efforts will bring. 🔶 This £2 million project, co-funded by UKRI, will support our pioneering automation approach focused on vitrification and its clinical validation. 🔶 The program will drive cutting-edge developments in vitrification technology and automation to improve reproductive outcomes and access to care. 🔶 This project brings together a distinguished consortium of institutions, each with their unique expertise: ➡ Conceivable, led by Dr Stephanie Kuku, MD, Charles Kingsland and Giuseppe Silvestri, PhD, will focus on developing novel vitrification techniques. ➡ King's College London and Christos Bergeles will support robotics and control improvements. ➡ Care Fertility and Tom Bamford will provide clinical expertise and support translational research efforts. We're thrilled to embark on this collaborative journey to advance the field of fertility. A huge thank you to all partners and team members involved! #FertilityResearch #Vitrification #UKRI #ReproductiveMedicine
-
At Conceivable Life Sciences, we think of ourselves as The Ultimate Family Business. Our purpose is clear: To help more people achieve the dream of becoming parents. Our vision is profound: A future in which infertility no longer determines who can start a family. We believe a key path to get there is through our pioneering end-to-end automation of the IVF lab. Change is coming. #IVF #IVFAutomation
-
-
"Normalization and credibility for this Nobel Prize winning therapy is critical to making IVF accessible to the millions of people who want to achieve the dream of becoming parents." --Joshua Abram, Co-founder & Chairman Conceivable Life Sciences
We've come a long way in terms of political leaders being willing to talk about how important IVF is in their lives. Michelle Obama made IVF a centerpiece of her mega best-selling memoir, having previously chosen not to speak about this part of her family's journey for over twenty years. IVF has become so powerful a uniting force—86% of Americans are in favor according to Gallup— that it's one of the few issues that bridges the country's great political schism. With examples such as Senator Tammy Duckworth, among the most liberal politicians in the country, and former VP Mike Pence, among the most conservative, describing their support of IVF in personal, "lived experience" language. And now, in his introductory speech to the nation as a VP nominee, Governor Tim Walz has shared his personal infertility story on the campaign trail with Vice President Kamala Harris. Normalization and credibility for this Nobel Prize winning therapy is critical to making IVF accessible to the millions of people who want to achieve the dream of becoming parents. #IVFAutomation #IVF Conceivable Life Sciences
-
In an article entitled “Robots and AI are Aiming to Make IVF Cheaper,” Bloomberg recognizes that the future of IVF is automated. At Conceivable Life Sciences, we not only agree--we’re leading the revolution. As Bloomberg journalist Kristen V. Brown notes, “Industry watchers say [Conceivable] is closest to automating nearly every step of the lab, with just one human embryologist, a lab technician, and an engineer to oversee it.“ Of course, we know that our world’s first end-to-end automation of the IVF lab will help with demand, but we’re even more encouraged by our early data showing we will improve results, which will also reduce costs. Or as Brown describes it: “The technology has the potential to improve the procedure’s success rate and lower costs, thereby expanding access to widely needed treatments that are out of reach for many.” As our founder Joshua Abram says, “This trifecta of improved results, increased scale, and reduced costs will move this Nobel Prize winning therapy from concierge medicine to a population health solution for the 1 in 6 people worldwide that suffer from infertility.” #IVFAutomation
-
On this day Miriam Menkin (1901-1992), the American scientist and pioneer of reproductive medicine was born. Best known for her work in the development of IVF at Harvard Medical School, Menkin made history in 1944 when she successfully fertilized a human egg outside the body, a breakthrough that laid the foundation for modern IVF technology. Despite working in an era when women faced significant barriers in science, Menkin's meticulous research and perseverance were instrumental in achieving this scientific milestone. Her work has provided hope for the 1 in 6 couples worldwide that are struggling with infertility and Miriam Menkin's legacy lives on in the millions of lives touched by IVF. Conceivable is building on the foundational work of this giant in the field as we create the world’s first end-to-end automated IVF lab, designed to improve outcomes, expand access, and reduce costs. #IVFAutomated #IVF #Fertility #WomenInSTEM
-
-
Our co-founder and chairman Joshua Abram on how Conceivable's end-to-end automation of the lab will improve results, lower cost, and allow IVF to scale to meet the true demand of 1 million+ babies a month. #IVFAutomation
Four years after the birth of the first IVF child, the first commercial cell phone, affectionately known as "the Brick”, was introduced. In today’s dollars it cost more than $10,000, requiring every penny from seven months of work for anyone earning the minimum wage to buy. The phone took 10 hours to charge, boasted 30 minutes of talk time, and stored 30 numbers. No surprise, in its first year of sales, only 7,000 were purchased. Fast forward to now: that “brick” has evolved to become a personal supercomputer, today accessible to more than 86% of the worldwide population. We live in a unique time in which the once impossible becomes routine. Through the deployment of technology, quality, scale, and price can simultaneously favor consumers. We know that utility in IVF is highly price elastic. A paper introduced to us by David Adamson, M.D. of the International Committee Monitoring Art (ICMART), demonstrates that for every 1 point increase in the price of ART depresses its utilization by 3.2%. So we need to stop talking about bringing the price per IVF baby down and actually do it. We desperately need the dynamic seen in the smartphone revolution to take hold in IVF, with new innovations focused on not adding expenses but lowering costs, improving outcomes, and helping IVF move beyond “concierge medicine for the rich” into a population health solution that’s widely available. When technology works, millions–sometimes billions–can access life-changing technology almost without regard to income. Conceivable’s mission is to make that “smart phone magic” happen in IVF. Currently only 5% of the world’s infertile couples can access care, largely due to the difficulty in scaling today’s expensive, manual, artisanal IVF labs. Our end-to-end automation of the lab will improve results, lower cost, and allow IVF to scale to meet the true demand of 1 million+ babies a month. Just watch us. #IVFAutomation Eduardo Gonzalez
-